These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 11172490

  • 1. Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma.
    Bialkowska-Hobrzanska H, Bowles L, Bukala B, Joseph MG, Fletcher R, Razvi H.
    Mol Diagn; 2000 Dec; 5(4):267-77. PubMed ID: 11172490
    [Abstract] [Full Text] [Related]

  • 2. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L, Bialkowska-Hobrzanska H, Bukala B, Nott L, Razvi H.
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [Abstract] [Full Text] [Related]

  • 3. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker.
    Melissourgos N, Kastrinakis NG, Davilas I, Foukas P, Farmakis A, Lykourinas M.
    Urology; 2003 Aug; 62(2):362-7. PubMed ID: 12893365
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCR.
    Yahyazadeh R, Bashash D, Ghaffari P, Kord S, Safaroghli-Azar A, Ghaffari SH.
    BMC Urol; 2021 Apr 19; 21(1):64. PubMed ID: 33874920
    [Abstract] [Full Text] [Related]

  • 5. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.
    Weikert S, Krause H, Wolff I, Christoph F, Schrader M, Emrich T, Miller K, Müller M.
    Int J Cancer; 2005 Nov 01; 117(2):274-80. PubMed ID: 15900578
    [Abstract] [Full Text] [Related]

  • 6. Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer.
    Isurugi K, Suzuki Y, Tanji S, Fujioka T.
    J Urol; 2002 Oct 01; 168(4 Pt 1):1574-7. PubMed ID: 12352460
    [Abstract] [Full Text] [Related]

  • 7. Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas.
    Longchampt E, Lebret T, Molinie V, Bieche I, Botto H, Lidereau R.
    BJU Int; 2003 Apr 01; 91(6):567-72. PubMed ID: 12656916
    [Abstract] [Full Text] [Related]

  • 8. Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
    Ito H, Kyo S, Kanaya T, Takakura M, Koshida K, Namiki M, Inoue M.
    Clin Cancer Res; 1998 Nov 01; 4(11):2807-10. PubMed ID: 9829746
    [Abstract] [Full Text] [Related]

  • 9. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y, Tsuchida T, Fukasawa M, Araki I, Tanabe N, Takeda M.
    Int J Urol; 2006 Apr 01; 13(4):401-8. PubMed ID: 16734859
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of urinary human telomerase reverse transcriptase mRNA and scatter factor protein as urine markers for diagnosis of bladder cancer.
    Eissa S, Motawi T, Badr S, Zaghlool A, Maher A.
    Clin Lab; 2013 Apr 01; 59(3-4):317-23. PubMed ID: 23724620
    [Abstract] [Full Text] [Related]

  • 11. Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer.
    Fukui T, Nonomura N, Tokizane T, Sato E, Ono Y, Harada Y, Nishimura K, Takahara S, Okuyama A.
    Mol Urol; 2001 Apr 01; 5(1):19-23. PubMed ID: 11689147
    [Abstract] [Full Text] [Related]

  • 12. Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer.
    Abd El Gawad IA, Moussa HS, Nasr MI, El Gemae EH, Masooud AM, Ibrahim IK, El Hifnawy NM.
    J Egypt Natl Canc Inst; 2005 Sep 01; 17(3):193-202. PubMed ID: 16799657
    [Abstract] [Full Text] [Related]

  • 13. Comparison of human telomerase RNA and telomerase activity in urine for diagnosis of bladder cancer.
    Müller M, Krause H, Heicappell R, Tischendorf J, Shay JW, Miller K.
    Clin Cancer Res; 1998 Aug 01; 4(8):1949-54. PubMed ID: 9717824
    [Abstract] [Full Text] [Related]

  • 14. Prospective evaluation of genetic abnormalities and telomerase expression in exfoliated urinary cells for bladder cancer detection.
    Neves M, Ciofu C, Larousserie F, Fleury J, Sibony M, Flahault A, Soubrier F, Gattegno B.
    J Urol; 2002 Mar 01; 167(3):1276-81. PubMed ID: 11832713
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G, Han W, Zhang ZF, Cordon-Cardo C, Saigo P, Fair WR, Herr H, Kim N, Moore MA.
    Clin Cancer Res; 1997 Sep 01; 3(9):1593-8. PubMed ID: 9815848
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relevance of urine telomerase in the diagnosis of bladder cancer.
    Sanchini MA, Gunelli R, Nanni O, Bravaccini S, Fabbri C, Sermasi A, Bercovich E, Ravaioli A, Amadori D, Calistri D.
    JAMA; 2005 Oct 26; 294(16):2052-6. PubMed ID: 16249419
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
    Gilbert SM, Veltri RW, Sawczuk A, Shabsigh A, Knowles DR, Bright S, O'Dowd GJ, Olsson CA, Benson MC, Sawczuk IS.
    Urology; 2003 Mar 26; 61(3):539-43. PubMed ID: 12639642
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.